bioRxivPathologyPreprint
MiRNA-223 Inhibits MouseGallstone Formation by Targeting Key Transporters in Hepatobiliary Cholesterol Secretion Pathway
F. Zhao, S. Ma, W. Shen, Y. Li, Z. Peng, X. Cui, L. Xing, X. Li, G. Liu, L. Jin, T. Ma, L. Shi
Abstract
BackgroudMiRNA-223 has previously been reported to play an essential role in hepatic cholesterol homeostasis by suppressing cholesterol synthesis, attenuating cholesterol uptake by hepatocyte from and promoting cholesterol efflux into the blood. However, its role in regulation of biliary cholesterol secretion and gallstone formation remains unknown. MethodsMice with conventional knockout (KO), hepatocyte-specific knockout ({Delta}Hepa) / knockdown (KD) or gain expression of miRNA-223 were included in the study and were subjected to lithogenic diet (LD) for various weeks. The gallbladders were harvested and subjected to cholesterol crystal imaging and gallstone mass measurement. Liver tissues were collected for western blotting, RT-qPCR, and immunohistochemistry staining. Levels of cholesterol, bile salt, phospholipids, and triglyceride were determined in serum, liver tissues, and bile by enzyme color reactive assays. 3 UTR reporter gene assays were used to verify the direct target genes for miRNA-223. ResultsLD-induced gallstone formation was remarkably accelerated in miRNA-223 KO, {Delta}Hepa, and KD mice with concurrent enhancement in total cholesterol levels in liver tissue and bile. Key biliary cholesterol transporters ABCG5 and ABCG8 were identified as direct targets of miRNA-223. Reversely, AAV-mediated hepatocyte-specific miRNA-223 overexpression prevented gallstone progression with reduced targets protein expression. ConclusionThe present study demonstrates a novel role of miRNA-223 in the regulation of hepatic bile cholesterol secretion pathway and gallstone formation by targeting ABCG5 and ABCG8 expression. Therefore, elevating miRNA-223 would be a potentially novel approach to overcome the sternness of cholesterol gallstone disease. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=173 SRC="FIGDIR/small/344580v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@1c418bforg.highwire.dtl.DTLVardef@134e20dorg.highwire.dtl.DTLVardef@e4e0d2org.highwire.dtl.DTLVardef@641b40_HPS_FORMAT_FIGEXP M_FIG C_FIG
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MicroRNA-27a is a key modulator of cholesterol biosynthesis
Abrar Ali Khan, Heena Agarwal, … Nitish R. Mahapatra·Molecular and Cellular BiologyPeer-reviewed·Feb 17, 2020
- ABCG5 ABCG8-independent mechanisms fail to maintain sterol balance in mice fed a high cholesterol diet
Garrett Anspach, Rupinder Kaur, … Gregory A. Graf·Journal of Lipid ResearchPeer-reviewed·Sep 16, 2025
- Cholesterol Metabolism in a Murine Model of Vertical Sleeve Gastrectomy
Emily C. Whang, Alessandra Ferrari, … Peter Tontonoz·bioRxiv·Jul 3, 2025
- ORP2 regulates free cholesterol accumulation in hepatocytes during MASH
Jin Wu, Yudi Zhao, … Hongyuan Yang·Hepatology CommunicationsPeer-reviewed·Jul 14, 2025
- Statins Stimulate Hepatic Glucose Production via the miR-183/96/182 Cluster
T. J. Marquart, R. M. Allen, … A. Baldan·bioRxiv·Aug 7, 2019
- Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
S. Ruiz-Gaspa, N. Guanabens, … A. Pares·bioRxiv·Jul 17, 2019